References
- HawkeyCJCOX-2 chronologyGut2005541509151416227351
- GibsonAC Oh willow, don’t weep. Available at: http://www.botgard.ucla.edu/html/botanytextbooks/economicbotany/salix/. Accessed Jun 10, 2010.
- JonesRNonsteroidal anti-inflammatory drug prescribing: Past, present and futureAm J Med20011104S7S11165987
- JackDBOne hundred years of aspirinLancet19973504374399259670
- DreserHPharmacologisches uber aspirin (acetylsalicyl saure)Pflugers Arch189976306
- Bayer AspirinHistory of aspirin2010 Available at: http://www.bayeraspirin.com/pain/asp_history.htm. Accessed Jun 10, 2010.
- CravenLLExperiences with aspirin (acetylsalicylic acid) in the non-specific prophylaxis of coronary thrombosisMiss Valley Med J195375384413013156
- O’BrienJREffects of salicylates on human plateletsLancet196817797834171129
- ElwoodPCCochraneALBurrMLA randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarctionBr Med J197414364404593555
- Antithrombotic Trialists’ CollaborationCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ2002324718611786451
- ChenZMSandercockPPanHCIndications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groupsStroke2000311240124910835439
- BaigentCBlackwellLCollinsRAntithrombotic Trialists’ (ATT) CollaborationAspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trialsLancet20093731849186019482214
- ZhangCSunAZhangPAspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysisDiabetes Res Clin Pract20108721121819853947
- PignoneMAlbertsMJColwellJAAspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology FoundationCirculation20101212694270120508178
- FowkesFGPriceJFStewartMCAspirin for Asymptomatic Atherosclerosis TrialistsAspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: A randomized controlled trialJAMA201030384184820197530
- BergerJSAspirin as preventive therapy in patients with asymptomatic vascular diseaseJAMA201030388088220197537
- BergerJSKrantzMJKittelsonJMHiattWRAspirin for the prevention of cardiovascular events in patients with peripheral artery disease: A meta-analysis of randomized trialsJAMA20093011909191919436018
- KrasopoulosGBristerSJBeattieWSBuchananMRAspirin “resistance” and risk of cardiovascular morbidity: Systematic review and meta-analysisBMJ200833619519818202034
- AjjanRStoreyRFGrantPJAspirin resistance and diabetes mellitusDiabetologia20085138539018197397
- DerrySLokeYKRisk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysisBMJ20003211183118711073508
- LanasAPerez-AisaMAFeuFInvestigators of the Asociación Española de Gastroenterología (AEG)A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal anti-inflammatory drug useAm J Gastroenterol20051001685169316086703
- DouthwaiteAHLintottSAMGastroscopic observation of the effect of aspirin and certain other substances on the stomachLancet1938212221225
- VonkemanHEvan de LaarMANonsteroidal anti-inflammatory drugs: Adverse effects and their preventionSemin Arthritis Rheum20103929431218823646
- ManesGBalzanoAMaronePLionielloMMoscaSAppropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy system: A prospective observational study based on the Maastricht guidelinesAliment Pharmacol Ther20021610511011856084
- YeomansNDLanasAITalleyNJPrevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirinAliment Pharmacol Ther20052279580116225488
- KellyJPKaufmanDWJurgelonJMSheehanJKoffRSShapiroSRisk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered productLancet1996348141314168937281
- WallaceJLNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred yearsGastroenterology1997112100010169041264
- ShiotaniAKamadaTHarumaKLow-dose aspirin induced gastrointestinal diseases: Past, present, and futureJ Gastroenterol20084358158818709479
- GrahamDYSmithJLDobbsSMGastric adaptation occurs with aspirin administration in manDig Dis Sci198323166600426
- GeallMGPhillipsSFSummerskillWHProfile of gastric potential difference in man. Effects of aspirin, alcohol, bile, and endogenous acidGastroenterology1970584374435437999
- LaineLMallerESYuCQuanHSimonTUlcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: A double blind trialGastroenterology2004127359402
- WeismanSMGrahamDYEvaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular eventsArch Intern Med20021622197220212390062
- McQuaidKRLaineLSystematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trialsAm J Med200611962463816887404
- SorensenHTMellemkjaerLBlotWJRisk of upper gastrointestinal bleeding associated with use of low-dose aspirinAm J Gastroenterol2000952218222411007221
- SinghGRosen RameyDNSAID-induced gastrointestinal complications: The ARAMIS perspective – 1997J Rheumatol Suppl1998518169596549
- US Preventive Services Task ForceAspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statementAnn Intern Med200915039640419293072
- HallasJDallMAndriesAUse of single and combined anti-thrombotic therapy and risk of serious upper gastrointestinal bleeding: Population based case-control studyBMJ200633372616984924
- LanasAScheimanJLow-dose aspirin and upper gastrointestinal damage: Epidemiology, prevention and treatmentCurr Med Res Opin20072316317317257477
- BhattDLScheimanJAbrahamNSAmerican College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus DocumentsCirculation20081181894190918836135
- LanasAGarcía-RodríguezLAArroyoMTAsociación Española de GastroenterologíaRisk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinationsGut2006551731173816687434
- SteinhublSRBhattDLBrennanDMCHARISMA InvestigatorsAspirin to prevent cardiovascular disease: The association of aspirin dose and clopidogrel with thrombosis and bleedingAnn Intern Med200915037938619293071
- HuntRHBazzoliFShould NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healingAliment Pharmacol Ther20041991614725573
- ChanFKGrahamDYPrevention of non-steroidal anti-inflammatory drug gastrointestinal complications – review and recommendations based on risk assessmentAliment Pharmacol Ther2004191051106115142194
- HuangJQSridharSHuntRHRole of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease, a meta-analysisLancet2002359142211809181
- VergaraMCatalánMGisbertJPCalvetXMeta-analysis, role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID usersAliment Pharmacol Ther2005211411141815948807
- LanasAFuentesJBenitoRSerranoPBajadorESáinzRHelicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirinAliment Pharmacol Ther20021677978611929396
- ChanFKChungSCSuenBYPreventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxenN Engl J Med200134496797311274623
- LaiKCLamSKChuKMLansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin useN Engl J Med20023462033203812087138
- RostomADubeCWellsGPrevention of NSAID-induced gastrointestinal ulcersCochrane Database Syst Rev20022CD00229612519573
- DonnellyMTGoddardAFFilipowiczBMorantSVShieldMJHawkeyCJLow-dose misoprostol for the prevention of low-dose aspirin-induced gastroduodenal injuryAliment Pharmacol Ther20001452953410792114
- TahaASMcCloskeyCPrasadRBezlyakVFamotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): A Phase III, randomised, double-blind, placebo-controlled trialLancet200937411912519577798
- LanasAGarcía-RodríguezLAArroyoMTInvestigators of the Asociación Española de Gastroenterología (AEG)Effect of anti-secretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulantsAm J Gastroenterol200710250751517338735
- LanasABajadorESerranoPNitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleedingN Engl J Med200034383483910995862
- SimonBElsnerHMüllerPProtective effect of omeprazole against low-dose acetylsalicylic acid. Endoscopic controlled double-blind study in healthy subjectsArzneimittelforschung1995457017037646574
- MüllerPFuchsWSimonBStudies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind studyArzneimittelforschung1997477587609281302
- YeomansNLanasALabenzJEfficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirinAm J Gastroenterol20081032465247318637091
- NgFHWongSYLamKFFamotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosionsGastroenterology2010138828819837071
- SungJJLauJYChingJYContinuation of low-dose aspirin therapy in peptic ulcer bleeding: A randomized trialAnn Intern Med20101521919949136
- WürtzMGroveELKristensenSDThe antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery diseaseHeart20109636837119910291
- HarkerLABoisselJPPilgrimAJGentMComparative safety and tolerability of clopidogrel and aspirin: Results from CAPRI. CAPRIE Steering Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic eventsDrug Saf19992132533510514023
- AndersonJLAdamsCDAntmanEMAmerican College of CardiologyAmerican Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction); American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Academic Emergency Medicine. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarctionCirculation2007116e138e304
- ChanFKChingJYHungLCClopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleedingN Engl J Med200535223824415659723
- LaiKCChuKMHuiWMEsomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complicationsClin Gastroenterol Hepatol2006486086516797240
- YusufSZhaoFMehtaSRChrolaviciusSTognoniGFoxKKClopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevationN Engl J Med200134549450211519503
- JuurlinkDNGomesTKoDTA population-based study of the drug interaction between proton pump inhibitors and clopidogrelCMAJ200918071371819176635
- GilardMArnaudBCornilyJCInfluence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin, the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) studyJ Am Coll Cardiol20085125626018206732
- Siller-MatulaJMSpielAOLangIMKreinerGChristGJilmaBEffects of pantoprazole and esomeprazole on platelet inhibition by clopidogrelAm Heart J2009157148.e1e519081411
- LaineLHennekensCProton pump inhibitor and clopidogrel interaction, fact or fiction?Am J Gastroenterol2009105344119904241